Endoglin regulates renal ischaemia-reperfusion injury

Nephrology Dialysis Transplantation

Volumn 21, Issue 8, 2006, Pages 2106-2119

  Docherty, Neil G ^a   López Novoa, José M ^a   Arevalo, Miguel ^a   Düwel, Annette ^a   Rodriguez Peña, Ana ^a   Pérez Barriocanal, Fernando ^a   Bernabeu, Carmelo ^b   Eleno, Nélida ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Endoglin; Fibrosis; Inflammation; Renal ischaemia reperfusion; TGF 1

Indexed keywords

COLLAGEN TYPE 4; ENDOGLIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOPEROXIDASE; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; GENE EXPRESSION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE NECROSIS; MACROPHAGE ACTIVATION; MALE; MORPHOLOGY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RAT STRAIN; REPERFUSION INJURY; UPREGULATION; VASCULAR ENDOTHELIUM; WILD TYPE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; COLLAGEN TYPE IV; CREATININE; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; FIBROSIS; GENE EXPRESSION REGULATION; HETEROZYGOTE; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KIDNEY TUBULAR NECROSIS, ACUTE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MONOCYTES; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE; RATS; RATS, WISTAR; REPERFUSION INJURY; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33748077088     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl179     Document Type: Article

References (29)

1. Grinyo JM. Role of ischemia-reperfusion injury in the development of chronic renal allograft damage. Transplant Proc 2001; 33: 3741-3742
2. Bains JC, Sandford RM, Brook NR, Hosgood SA, Lewis GR, Nicholson ML. Comparison of renal allograft fibrosis after transplantation from heart-beating and non-heart-beating donors. Br J Surg 2005; 92: 113-118
3. Sienko J, Wisniewska M, Ostrowski M et al. Impact of selected factors on early graft function in patients after renal transplantation. Transplant Proc 2003; 35: 2167-2169
4. Lastres P, Bellon T, Cabanas C et al. Regulated expression on human macrophages of Endoglin, an Arg-Gly-Asp-containing surface antigen. Eur J Immunol 1992; 22: 393-397
5. Adam PJ, Clesham GJ, Weissberg PL. Expression of endoglin mRNA and protein in human vascular smooth muscle cells. Biochem Biophys Res Commun 1998; 247: 33-37
6. Diez-Marques L, Ortega-Velazquez R, Langa C et al. Expression of Endoglin in human mesangial cells: Modulation of extracellular matrix synthesis. Biochim Biophys Acta 2002; 1587: 36-44
7. Rodriguez-Barbero A, Obreo J, Eleno N et al. Endoglin expression in human and rat mesangial cells and its upregulation by TGF-beta1. Biochem Biophys Res Commun 2001; 282: 142-147
8. Bourdeau A, Dumont DJ, Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 1999; 104: 1343-1351
9. Arthur HM, Ure J, Smith AJ et al. Endoglin, an ancillary TGF beta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 2000; 217: 42-53
10. Jerkic M, Rivas-Elena JV, Prieto M et al. Endoglin regulates nitric oxide-dependent vasodilatation. FASEB J 2004; 18: 609-616
11. Lastres P, Letamendia, Zhang H et al. Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol 1996; 133: 1109-1121
12. Guerrero-Esteo M, Lastres P, Letamendia A et al. Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblasts. Eur J Cell Biol 1999; 78: 614-623
13. Li C, Hampson IN, Hampson L, Kumar P, Bernabeu C, Kumar S. CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. FASEB J 2000; 14: 55-64
14. Ma X, Labinaz M, Goldstein J et al. Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration. Arterioscler Thromb Vasc Biol 2000; 20: 2546-2552
15. Roy-Chaudhury P, Simpson JG, Power DA. Endoglin, a transforming growth factor-beta-binding protein, is upregulated in chronic progressive renal disease. Exp Nephrol 1997; 5: 55-60
16. Rodriguez-Peña A, Prieto M, Duwel A et al. Up-regulation of Endoglin, a TGF-beta-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction. Nephrol Dial Transplant 2001; 16: 34-39
17. Rodriguez-Peña A, Eleno N, Duwell A et al. Endoglin upregulation during experimental renal interstitial fibrosis in mice. Hypertension 2002; 40: 713-720
18. Botella LM, Sanchez-Elsner T, Rius C, Corbi A, Bernabeu C. Identification of a critical Sp1 site within the Endoglin promoter and its involvement in the transforming growth factor-beta stimulation. J Biol Chem 2001; 276: 34486-34494
19. Li D, Chen H, Mehta JL. Angiotensin II via activation of type 1 receptor upregulates expression of Endoglin in human coronary artery endothelial cells. Hypertension 2001; 38: 1062-1067
20. Sanchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabeu C. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem 2002; 277: 43799-43808
21. Jerkic M, Miloradovic Z, Jovovic D et al. Relative roles of endothelin-1 and angiotensin II in experimental postischaemic acute renal failure. Nephrol Dial Transplant 2004; 19: 83-94
22. Rodriguez-Peña A, Garcia-Criado FJ, Eleno N, Arevalo M, Lopez-Novoa JM. Intrarenal administration of molsidomine, a molecule releasing nitric oxide, reduces renal ischemia-reperfusion injury in rats. Am J Transplant 2004; 4: 1605-1613
23. García-Criado FJ, Eleno N, Santos-Benito F et al. Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of renal ischemia-reperfusion. Transplantation 1998; 66: 982-990
24. Chatterjee PK, Patel NS, Sivarajah A et al. GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia-reperfusion, Kidney Int. 2003; Mar; 63: 853-865.
25. Torsney E, Charlton R, Parums D, Collis M, Arthur HM. Inducible expression of human Endoglin during inflammation and wound healing in vivo. Inflamm Res 2002; 51: 464-470
26. Conley BA, Smith JD, Guerrero-Esteo M, Bernabeu C, Vary CP. Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques. Atherosclerosis 2000; 153: 323-335
27. Alevriadou BR. CAMs and Rho small GTPases: Gatekeepers for leukocyte transendothelial migration. Focus on 'VCAM-1- mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration'. Am J Physiol Cell Physiol 2003; 285: C250-C252
28. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 2004; 66: 486-491
29. Assoian RK, Fleurdelys BE, Stevenson HC et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987;84: 6020-6024